← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2014Last known activity
Jan 4, 2023
Timeline
2000s
- Jun 1, 2002
Frontier Biotechnologies Co., Ltd.— Founded
Drugs by trial phase (8 distinct, 13 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT05675072Lead sponsorPhase 2/Phase 3Jan 4, 2023
- NCT05675072Study directorPhase 2/Phase 3Jan 4, 2023
- NCT05583812Lead sponsorPhase 1Oct 21, 2022
- NCT05445934Lead sponsorPhase 2/Phase 3Jul 5, 2022
- NCT05445934Study directorPhase 2/Phase 3Jul 5, 2022
- NCT05415241CollaboratorPhase 1/Phase 2Jun 9, 2022
- NCT05206019Lead sponsorPhase 1Feb 1, 2022
- NCT05197179Lead sponsorPhase 1Dec 29, 2021
- NCT04819347Lead sponsorPhase 2May 1, 2021
- NCT04819347Study directorPhase 2May 1, 2021
- NCT04766931Study directorPhase 1Mar 26, 2021
- NCT04766931Lead sponsorPhase 1Mar 26, 2021
- NCT04560569Lead sponsorPhase 2Dec 25, 2020
- NCT04560569Study directorPhase 2Dec 25, 2020
- NCT03997734Lead sponsorPhase 1Jun 30, 2019
Details
- Founded
- Nanjing, CN Jun 1, 2002
- Last known activity
- Jan 4, 2023